Tourmaline_logo.jpg
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
14. November 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio to Host Investor Day on Tuesday, December 10, 2024
Tourmaline_logo.jpg
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
07. November 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline_logo.jpg
Tourmaline Bio to Present at Upcoming Investor Conferences
31. Oktober 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences
Tourmaline_logo.jpg
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November 1, 2024
15. Oktober 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio to Host Expert Webinar on Human Genetic Validation for IL-6 Inhibition in Cardiovascular Disease with Dr. Dipender Gill on Friday, November
Tourmaline_logo.jpg
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
11. Oktober 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio to Showcase Two Poster Presentations at the 2024 Cardiometabolic Health Congress
Tourmaline_logo.jpg
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
08. Oktober 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio Announces Formation of Cardiovascular Scientific Advisory Board
Tourmaline_logo.jpg
Tourmaline Bio to Present at Upcoming Investor Conferences
03. September 2024 07:45 ET | Tourmaline Bio, Inc.
Tourmaline Bio to Present at Upcoming Investor Conferences
Tourmaline_logo.jpg
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
08. August 2024 07:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio Reports Second Quarter 2024 Financial Results and Recent Business Highlights
Tourmaline_logo.jpg
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
02. August 2024 16:30 ET | Tourmaline Bio, Inc.
Tourmaline Bio Presents Phase 2 TRANQUILITY Study Design at American Society of Preventive Cardiology (ASPC) Congress 2024
Tourmaline_logo.jpg
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer
27. Juni 2024 08:05 ET | Tourmaline Bio, Inc.
Tourmaline Bio Announces the Promotion of Ryan Robinson to Chief Financial Officer